Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06463457
Title Comeback From Long coursE ADT With RElugolix and Darolutamide (CLEARED)
Acronym CLEARED
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Atish Choudhury, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.